Akumin Inc. (TSE:AKU – Get Rating) – Investment analysts at National Bank Financial decreased their FY2022 EPS estimates for Akumin in a report issued on Sunday, November 13th. National Bank Financial analyst E. Leno now expects that the company will earn ($1.42) per share for the year, down from their prior forecast of ($1.06). The consensus estimate for Akumin’s current full-year earnings is ($0.79) per share. National Bank Financial also issued estimates for Akumin’s FY2023 earnings at ($1.14) EPS.
Separately, Clarus Securities reiterated a “buy” rating and issued a C$6.75 price objective on shares of Akumin in a report on Monday, August 15th.
Akumin Stock Down 5.1 %
Akumin Company Profile
Akumin Inc provides outpatient diagnostic imaging services in the United States. It operates in two segments, Radiology and Oncology. The company offers various medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, digital radiography, fluoroscopy, and other diagnostic or interventional radiology procedures through a network of approximately 200 owned and/or operated imaging locations.
- International Game Technology is Well Worth the Gamble
- Use The Airbnb Stock Implosion to Your Advantage
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Why Lowe’s Is Up And Home Depot Down
- The TJX Companies Could Break Out To New Highs
Receive News & Ratings for Akumin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akumin and related companies with MarketBeat.com's FREE daily email newsletter.